Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

The 20 Most-Frequently Read Articles
Category: All

in J Clin Oncol during January 2015 -- updated monthly

Most-read rankings are recalculated at the beginning of the month and are based on abstract, full-text and pdf views.

1.  Gregory A. Masters, Lada Krilov, Howard H. Bailey, Marcia S. Brose, Harold Burstein, Lisa R. Diller, Don S. Dizon, Howard A. Fine, Gregory P. Kalemkerian, Mark Moasser, Michael N. Neuss, Steven J. O''Day, Olatoyosi Odenike, Charles J. Ryan, Richard L. Schilsky, Gary K. Schwartz, Alan P. Venook, Sandra L. Wong, Jyoti D. Patel
  Clinical Cancer Advances 2015: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology
  J. Clin. Oncol. Jan 20, 2015; doi: 10.1200/JCO.2014.59.9746.
(In "ASCO SPECIAL ARTICLES")   [Full Text]     [PDF]
2.  Bella Kaufman, Ronnie Shapira-Frommer, Rita K. Schmutzler, M. William Audeh, Michael Friedlander, Judith Balmaña, Gillian Mitchell, Georgeta Fried, Salomon M. Stemmer, Ayala Hubert, Ora Rosengarten, Mariana Steiner, Niklas Loman, Karin Bowen, Anitra Fielding, Susan M. Domchek
  Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <I>BRCA1/2</I> Mutation
  J. Clin. Oncol. Jan 20, 2015; 33: 244-250.
(In "Rapid Communications")   [Abstract]     [Full Text]     [PDF]
3.  William M. Sikov, Donald A. Berry, Charles M. Perou, Baljit Singh, Constance T. Cirrincione, Sara M. Tolaney, Charles S. Kuzma, Timothy J. Pluard, George Somlo, Elisa R. Port, Mehra Golshan, Jennifer R. Bellon, Deborah Collyar, Olwen M. Hahn, Lisa A. Carey, Clifford A. Hudis, Eric P. Winer
  Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)
  J. Clin. Oncol. Jan 01, 2015; 33: 13-21.
(In "Rapid Communications")   [Abstract]     [Full Text]     [PDF]
4.  Jeffrey S. Weber, Laura A. Levit, Peter C. Adamson, Suanna Bruinooge, Howard A. Burris, Michael A. Carducci, Adam P. Dicker, Mithat G&ouml;nen, Stephen M. Keefe, Michael A. Postow, Michael A. Thompson, David M. Waterhouse, Susan L. Weiner, Lynn M. Schuchter
  American Society of Clinical Oncology Policy Statement Update: The Critical Role of Phase I Trials in Cancer Research and Treatment
  J. Clin. Oncol. Jan 20, 2015; 33: 278-284.
(In "ASCO SPECIAL ARTICLES")   [Full Text]     [PDF]
5.  Grzegorz S. Nowakowski, Betsy LaPlant, William R. Macon, Craig B. Reeder, James M. Foran, Garth D. Nelson, Carrie A. Thompson, Candido E. Rivera, David J. Inwards, Ivana N. Micallef, Patrick B. Johnston, Luis F. Porrata, Stephen M. Ansell, Randy D. Gascoyne, Thomas M. Habermann, Thomas E. Witzig
  Lenalidomide Combined With R-CHOP Overcomes Negative Prognostic Impact of Non&#8211;Germinal Center B-Cell Phenotype in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Study
  J. Clin. Oncol. Jan 20, 2015; 33: 251-257.
(In "Rapid Communications")   [Abstract]     [Full Text]     [PDF]
6.  Elena M. Stoffel, Pamela B. Mangu, Stephen B. Gruber, Stanley R. Hamilton, Matthew F. Kalady, Michelle Wan Yee Lau, Karen H. Lu, Nancy Roach, Paul J. Limburg
  Hereditary Colorectal Cancer Syndromes: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the Familial Risk&#8211;Colorectal Cancer: European Society for Medical Oncology Clinical Practice Guidelines
  J. Clin. Oncol. Jan 10, 2015; 33: 209-217.
(In "ASCO SPECIAL ARTICLES")   [Abstract]     [Full Text]     [PDF]
7.  Se Hoon Park, Tae Sung Sohn, Jeeyun Lee, Do Hoon Lim, Min Eui Hong, Kyoung-Mee Kim, Insuk Sohn, Sin Ho Jung, Min Gew Choi, Jun Ho Lee, Jae Moon Bae, Sung Kim, Seung Tae Kim, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang
  Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses
  J. Clin. Oncol. Jan 05, 2015; doi: 10.1200/JCO.2014.58.3930.
(In "Gastrointestinal Cancer")   [Abstract]     [Full Text]     [PDF]
8.  Jean-Francois Boileau, Brigitte Poirier, Mark Basik, Claire M.B. Holloway, Louis Gaboury, Lucas Sideris, Sarkis Meterissian, Angel Arnaout, Muriel Brackstone, David R. McCready, Stephen E. Karp, Isabelle Trop, Andre Lisbona, Frances C. Wright, Rami J. Younan, Louise Provencher, Erica Patocskai, Atilla Omeroglu, Andre Robidoux
  Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: The SN FNAC Study
  J. Clin. Oncol. Jan 20, 2015; 33: 258-264.
(In "Breast Cancer")   [Abstract]     [Full Text]     [PDF]
9.  Bernard Nordlinger, Graeme J. Poston, Richard M. Goldberg
  Should the Results of the New EPOC Trial Change Practice in the Management of Patients With Resectable Metastatic Colorectal Cancer Confined to the Liver?
  J. Clin. Oncol. Jan 20, 2015; 33: 241-243.
(In "Comments and Controversies")   [Full Text]     [PDF]
10.  Michael A. Postow, Margaret K. Callahan, Jedd D. Wolchok
  Immune Checkpoint Blockade in Cancer Therapy
  J. Clin. Oncol. Jan 20, 2015; doi: 10.1200/JCO.2014.59.4358.
(In "REVIEW ARTICLES")   [Abstract]     [Full Text]     [PDF]
11.  Alan P. Venook, Josep Tabernero
  Progression-Free Survival: Helpful Biomarker or Clinically Meaningless End Point?
  J. Clin. Oncol. Jan 01, 2015; 33: 4-6.
(In "EDITORIALS")   [Full Text]     [PDF]
12.  Laurence Klotz, Danny Vesprini, Perakaa Sethukavalan, Vibhuti Jethava, Liying Zhang, Suneil Jain, Toshihiro Yamamoto, Alexandre Mamedov, Andrew Loblaw
  Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer
  J. Clin. Oncol. Jan 20, 2015; 33: 272-277.
(In "Urologic Oncology")   [Abstract]     [Full Text]     [PDF]
13.  John R. Mackey, Manuel Ramos-Vazquez, Oleg Lipatov, Nicole McCarthy, Dmitriy Krasnozhon, Vladimir Semiglazov, Alexey Manikhas, Karen A. Gelmon, Gottfried E. Konecny, Marc Webster, Roberto Hegg, Sunil Verma, Vera Gorbunova, Dany Abi Gerges, Francois Thireau, Helena Fung, Lorinda Simms, Marc Buyse, Ayman Ibrahim, Miguel Martin
  Primary Results of ROSE/TRIO-12, a Randomized Placebo-Controlled Phase III Trial Evaluating the Addition of Ramucirumab to First-Line Docetaxel Chemotherapy in Metastatic Breast Cancer
  J. Clin. Oncol. Jan 10, 2015; 33: 141-148.
(In "Rapid Communications")   [Abstract]     [Full Text]     [PDF]
14.  Justin E. Bekelman, Nandita Mitra, Elizabeth A. Handorf, Robert G. Uzzo, Stephen A. Hahn, Daniel Polsky, Katrina Armstrong
  Effectiveness of Androgen-Deprivation Therapy and Radiotherapy for Older Men With Locally Advanced Prostate Cancer
  J. Clin. Oncol. Jan 05, 2015; doi: 10.1200/JCO.2014.57.2743.
(In "Urologic Oncology")   [Abstract]     [Full Text]     [PDF]
15.  George T. Budd, William E. Barlow, Halle C.F. Moore, Timothy J. Hobday, James A. Stewart, Claudine Isaacs, Muhammad Salim, Jonathan K. Cho, Kristine J. Rinn, Kathy S. Albain, Helen K. Chew, Gary V. Burton, Timothy D. Moore, Gordan Srkalovic, Bradley A. McGregor, Lawrence E. Flaherty, Robert B. Livingston, Danika L. Lew, Julie R. Gralow, Gabriel N. Hortobagyi
  SWOG S0221: A Phase III Trial Comparing Chemotherapy Schedules in High-Risk Early-Stage Breast Cancer
  J. Clin. Oncol. Jan 01, 2015; 33: 58-64.
(In "Breast Cancer")   [Abstract]     [Full Text]     [PDF]
16.  Qian Shi, Aimery de Gramont, Axel Grothey, John Zalcberg, Benoist Chibaudel, Hans-Joachim Schmoll, Matthew T. Seymour, Richard Adams, Leonard Saltz, Richard M. Goldberg, Cornelis J.A. Punt, Jean-Yves Douillard, Paulo M. Hoff, Joel Randolph Hecht, Herbert Hurwitz, Eduardo D&iacute;az-Rubio, Rainer Porschen, Niall C. Tebbutt, Charles Fuchs, John Souglakos
  Individual Patient Data Analysis of Progression-Free Survival Versus Overall Survival As a First-Line End Point for Metastatic Colorectal Cancer in Modern Randomized Trials: Findings From the Analysis and Research in Cancers of the Digestive System Database
  J. Clin. Oncol. Jan 01, 2015; 33: 22-28.
(In "Gastrointestinal Cancer")   [Abstract]     [Full Text]     [PDF]
17.  Gary H. Lyman, Kari Bohlke, Alok A. Khorana, Nicole M. Kuderer, Agnes Y. Lee, Juan Ignacio Arcelus, Edward P. Balaban, Jeffrey M. Clarke, Christopher R. Flowers, Charles W. Francis, Leigh E. Gates, Ajay K. Kakkar, Nigel S. Key, Mark N. Levine, Howard A. Liebman, Margaret A. Tempero, Sandra L. Wong, Mark R. Somerfield, Anna Falanga
  Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
  J. Clin. Oncol. Jan 20, 2015; doi: 10.1200/JCO.2014.59.7351.
(In "ASCO SPECIAL ARTICLES")   [Abstract]     [Full Text]     [PDF]
18.  Peter A. Kaufman, Ahmad Awada, Chris Twelves, Louise Yelle, Edith A. Perez, Galina Velikova, Martin S. Olivo, Yi He, Corina E. Dutcus, Javier Cortes
  Phase III Open-Label Randomized Study of Eribulin Mesylate Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
  J. Clin. Oncol. Jan 20, 2015; doi: 10.1200/JCO.2013.52.4892.
(In "Breast Cancer")   [Abstract]     [Full Text]     [PDF]
19.  Calin Cainap, Shukui Qin, Wen-Tsung Huang, Ik Joo Chung, Hongming Pan, Ying Cheng, Masatoshi Kudo, Yoon-Koo Kang, Pei-Jer Chen, Han-Chong Toh, Vera Gorbunova, Ferry A.L.M. Eskens, Jiang Qian, Mark D. McKee, Justin L. Ricker, Dawn M. Carlson, Saied El-Nowiem
  Linifanib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: Results of a Randomized Phase III Trial
  J. Clin. Oncol. Jan 10, 2015; 33: 172-179.
(In "Gastrointestinal Cancer")   [Abstract]     [Full Text]     [PDF]
20.  Dung T. Le, Andrea Wang-Gillam, Vincent Picozzi, Tim F. Greten, Todd Crocenzi, Gregory Springett, Michael Morse, Herbert Zeh, Deirdre Cohen, Robert L. Fine, Beth Onners, Jennifer N. Uram, Daniel A. Laheru, Eric R. Lutz, Sara Solt, Aimee Luck Murphy, Justin Skoble, Ed Lemmens, John Grous, Thomas Dubensky
  Safety and Survival With GVAX Pancreas Prime and <I>Listeria Monocytogenes</I>&#8211;Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer
  J. Clin. Oncol. Jan 12, 2015; doi: 10.1200/JCO.2014.57.4244.
(In "Rapid Communications")   [Abstract]     [Full Text]     [PDF]
rss gif Subscribe to Most Read feed

Last Updated: 02/07/2015 04:39:09

 Librarians &
 Rights &
 PDA Services

Copyright © 2015 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online